Related Experiment Video

Updated: May 20, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

The Link Between Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infection and Type 2 Inflammation in

Bei Ye1, Shu Teng1, Lu Zhan2

  • 1Hangzhou Children's Hospital, Hangzhou, China.

Clinical Pediatrics
|March 24, 2025
PubMed

Insights

Respiratory syncytial virus (RSV) lower respiratory tract infections (LRTI) in children are linked to type 2 inflammation, a response also seen in asthma. Biomarkers like IL-13 and IgE indicate this inflammatory pattern.

Area of Science:

  • Pediatric respiratory diseases
  • Immunology
  • Inflammatory responses

Background:

  • Asthma is characterized by a type 2 inflammatory response.
  • Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infection (LRTI) in children.

Purpose of the Study:

  • To investigate the association between type 2 inflammation and RSV-induced LRTI in children.
  • To identify potential biomarkers for type 2 inflammation in pediatric RSV LRTI.

Main Methods:

  • Compared biomarker levels (IL-13, IgE, MUC5AC, EOS) in 67 children with RSV LRTI and 27 healthy children.
  • Utilized rank sum tests and Receiver Operating Characteristic (ROC) curves for analysis.

Main Results:

  • Children with RSV LRTI showed significantly higher levels of IL-13, IgE, MUC5AC, and EOS compared to controls (P < .05).
  • ROC analysis indicated that IL-13, IgE, MUC5AC, and EOS could predict type 2 inflammation with varying accuracy.

Conclusions:

  • RSV-induced LRTIs in children may be associated with a type 2 inflammatory response.
  • Biomarkers such as IL-13, IgE, MUC5AC, and EOS may indicate type 2 inflammation following RSV LRTI.
Abstract

Keywords:
IL-13IgEMUC5ACeosinophils (EOS)respiratory syncytial virus (RSV)type 2 asthma (T2 asthma)

More Related Videos

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation09:56

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

10.1K
Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

29.9K

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
320
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
293
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
194